Pulmonary Fibrosis in COVID-19 Recovered Patients: Problem and Potential Management
Author:
Publisher
Jaypee Brothers Medical Publishing
Subject
Critical Care and Intensive Care Medicine
Link
https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-23733
Reference15 articles.
1. 1. Zhang P, Li J, Liu H, Han N, Ju J, Kou Y, et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res 2020;8:8. DOI: 10.1038/s41413-020-0084-5.
2. 2. Das KM, Lee EY, Singh R, Enani MA, Al Dossari K, Van Gorkom K, et al. Follow up chest radiographic findings in patients with MERS-CoV after recovery. Indian J Radiol Imaging 2017;27(3):342–349. DOI: 10.4103/ijri.IJRI_469_16.
3. 3. Lee N, Hui D, Wu A, Chan P, Cameron P, Joyn GM, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003;348(20):1986–1994. DOI: 10.1056/NEJMoa030685.
4. 4. Chiang CH, Shih JF, Su WJ, Perng RP. Eight-month prospective study of 14 patients with hospital-acquired severe acute respiratory syndrome. Mayo Clin Proc 2004;79(11):1372–1379. DOI: 10.4065/79.11.1372.
5. 5. Thille AW, Esteban A, Fernández-Segoviano P, Rodriguez JM, Aramburu JA, Vargas-Errázuriz P, et al. Chronology of histological lesions in acute respiratory distress syndrome with diff use alveolar damage: a prospective cohort study of clinical autopsies. Lancet Respir Med 2013;1(5):395–401. DOI: 10.1016/S2213-2600(13)70053-5.
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Chinese classical prescription Maimendong decoction in treatment of pulmonary fibrosis: an overview;Frontiers in Pharmacology;2024-05-09
2. Pharmacological approaches to pulmonary fibrosis following COVID-19;Frontiers in Pharmacology;2023-06-15
3. Long course of low-dose dexamethasone following or after bleomycin administration ameliorates pulmonary fibrosis;International Immunopharmacology;2022-12
4. Tocotrienol-Rich Fractions Offer Potential to Suppress Pulmonary Fibrosis Progression;International Journal of Molecular Sciences;2022-11-18
5. Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals;Inflammopharmacology;2022-08-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3